Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The enhanced renin-angiotensin-aldosteron system pharmacological blockade--which is the best?
Tylicki L, Lizakowski S, Rutkowski P, Renke M, Sulikowska B, Heleniak Z, Donderski R, Bednarski R, Przybylska M, Manitius J, Rutkowski B. Tylicki L, et al. Among authors: heleniak z. Kidney Blood Press Res. 2012;36(1):335-43. doi: 10.1159/000343391. Epub 2012 Dec 12. Kidney Blood Press Res. 2012. PMID: 23235363 Free article. Clinical Trial.
Effect of aliskiren on proteinuria in non-diabetic chronic kidney disease: a double-blind, crossover, randomised, controlled trial.
Lizakowski S, Tylicki L, Renke M, Rutkowski P, Heleniak Z, Sławińska-Morawska M, Aleksandrowicz E, Łysiak-Szydłowska W, Rutkowski B. Lizakowski S, et al. Among authors: heleniak z. Int Urol Nephrol. 2012 Dec;44(6):1763-70. doi: 10.1007/s11255-011-0110-z. Int Urol Nephrol. 2012. PMID: 23326865 Free PMC article. Clinical Trial.
Safety of enhanced renin-angiotensin-aldosterone system inhibition with aliskiren in nondiabetic patients with chronic kidney disease.
Lizakowski S, Tylicki L, Rutkowski P, Renke M, Sulikowska B, Heleniak Z, Donderski R, Bednarski R, Przybylska M, Manitius J, Rutkowski B. Lizakowski S, et al. Among authors: heleniak z. Pol Arch Med Wewn. 2013;123(5):221-7. doi: 10.20452/pamw.1726. Epub 2013 Apr 25. Pol Arch Med Wewn. 2013. PMID: 23615633 Free article. Clinical Trial.
Aliskiren attenuates oxidative stress and improves tubular status in non-diabetic patients with chronic kidney disease-Placebo controlled, randomized, cross-over study.
Renke M, Lizakowski S, Tylicki L, Rutkowski P, Knap N, Heleniak Z, Sławińska-Morawska M, Aleksandrowicz-Wrona E, Januszczyk J, Wójcik-Stasiak M, Małgorzewicz S, Woźniak M, Rutkowski B. Renke M, et al. Among authors: heleniak z. Adv Med Sci. 2014 Sep;59(2):256-60. doi: 10.1016/j.advms.2014.03.003. Epub 2014 Jun 10. Adv Med Sci. 2014. PMID: 25105662 Clinical Trial.
Nonsteroidal anti-inflammatory drug use in patients with chronic kidney disease.
Heleniak Z, Cieplińska M, Szychliński T, Rychter D, Jagodzińska K, Kłos A, Kuźmiuk I, Tylicka MJ, Tylicki L, Rutkowski B, Dębska-Ślizień A. Heleniak Z, et al. J Nephrol. 2017 Dec;30(6):781-786. doi: 10.1007/s40620-016-0352-z. Epub 2016 Sep 27. J Nephrol. 2017. PMID: 27679400 Free PMC article.
57 results